282
Participants
Start Date
June 28, 2017
Primary Completion Date
May 28, 2020
Study Completion Date
September 1, 2021
Coenzyme Q10 plus NADH
"Active arm: Coenzyme Q10 plus NADH CFS/ME patients who will be randomized to measure the effect of oral ReConnect supplementation (CoQ10: 200 mg/day plus NADH 20 mg/day; 4 tablets/day) on changes in the fatigue, sleep problems, autonomic function and HRQoL during 8-weeks in term.~Intervention: Reconnect"
phosphoserine plus vitamin C
"Placebo arm: phosphoserine plus vitamin C CFS/ME patients who will be randomized to measure the effect of oral Placebo supplementation (phosphoserine and vit C, 4 tablets/day) on changes in the fatigue, sleep problems, autonomic function and HRQoL during 8-weeks in term.~Intervention: placebo"
Vall d'Hebron University Hospital, Barcelona
Vitae Health Innovation
INDUSTRY
Hospital Universitari Vall d'Hebron Research Institute
OTHER